等待开盘 08-21 09:30:00 美东时间
-0.530
-7.82%
(来源:求实药社) 2026年8月10日,Avere Therapeutics,一家私人控股的生物技术公司,致力于为IL-23驱动的炎症性疾病提供口服疗法,宣布...
08-11 12:25
NextCure (NASDAQ:NXTC) reported quarterly losses of $(2.80) per share which missed the analyst consensus estimate of $(1.94) by 45.08 percent. This is a 75.2 percent increase over losses of $(11.29) per share from the same period last year.
08-07 05:47
虎牙涨-12.50%;AST SPACEMOBILE涨-11.66%;巨龙在线涨-9.67%
07-16 08:05
Vivakor涨-28.05%;Twin Vee PowerCats涨-25.47%;NextCure涨-19.45%
07-15 08:05
长飞光纤预计上半年净利同比增超711%!天齐锂业、赣锋锂业齐发盈喜,天齐预计上半年净利增逾3276%;领益智造进军光通信!拟斥40亿参与富通嘉善重组 >>
07-15 07:48
多家股东权利律师事务所已对生物技术公司NextCure启动调查,事涉该公司与Avere Therapeutics的合并交易可能损害股东利益。受调查消息影响...
07-15 03:37
NextCure, Inc. (NASDAQ:NXTC) ("NextCure") and Avere Therapeutics, Inc. ("Avere"), a privately-held biotechnology company advancing oral therapies for IL-23 driven inflammatory diseases, today announced they have entered into a definitive merger agreement (the "Agreement") for an all-stock transactio...
07-14 18:05